Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 18,265 | 17,336 | 20,750 | 15,288 | 14,108 |
| Cost of Goods | 262 | N/A | N/A | N/A | N/A |
| Gross Profit | 18,003 | 17,279 | 20,750 | 15,288 | 14,108 |
| Operating Expenses | 97,080 | 103,604 | 100,747 | 87,954 | 78,808 |
| Operating Income | -78,815 | -86,268 | -79,997 | -72,666 | -64,700 |
| Interest Expense | 336 | 346 | 393 | 391 | 382 |
| Other Income | 5,826 | 5,686 | 6,274 | 6,935 | 7,879 |
| Pre-tax Income | -73,325 | -80,928 | -74,116 | -66,122 | -57,203 |
| Income Tax | 8 | 71 | N/A | N/A | 226 |
| Net Income Continuous | -73,333 | -80,999 | -74,116 | -66,122 | -57,429 |
| Net Income | $-73,333 | $-80,999 | $-74,116 | $-66,122 | $-57,429 |
| EPS Basic Total Ops | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 |
| EPS Basic Continuous Ops | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 |
| EPS Diluted Total Ops | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 |
| EPS Diluted Continuous Ops | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.92 | -0.85 | -0.75 | -0.66 |
| EBITDA(a) | $-79,360 | $-87,247 | $-81,757 | $-74,962 | $-67,121 |